There are a number of obstacles confronting today’s clinical trial research field:• Failure to accrue sufficient participants. Protocols designed without the benefit of real...
Grupy tematyczne Klastra (ang. SIG - Special Interest Groups) mogą wnosić w działalność Partnerów Klastra nową jakość, ale muszą spełniać pewne warunki, które pozwolą...
Introduction - the problem:Treatment of oncological patients with targeted therapy has been carried out in our country for over 15 years. However, compared to...
Treatment decisions in oncology are commonly informed by the visual assessment of immunohistochemistry biomarkers by pathologists. However, pathology services face mounting pressure as diagnostic...



